Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated With Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen

NCT02118896 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.

NCT NCT02118896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02118896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated With Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen
Lead sponsor
Astellas Pharma Europe Ltd.
Phase
Phase 3
Overall status
Completed
Start date
February 24, 2003
Completion date
October 7, 2009
Enrollment
850 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplantation, kidney transplantation, liver transplantation